Singapore, March 27 -- The Health Sciences Authority received information related to the study titled 'A phase I open-label, multi-center study to evaluate the safety, tolerability, dosimetry, and preliminary activity of [177Lu] Lu-DFC413 and safety and imaging properties of [68Ga] Ga-NNS309 in patients with solid tumors'. The following are the other relevant details related to the trial:
Therapeutic Area: Oncology (including Haematology-Oncology)
Trial Centre(s):
National Cancer Centre
National University Hospital
Trial Status: Ongoing, Recruiting
Not Yet Recruiting
Principal Investigator(s):
Dr. Aaron Chia-Ken Tan
Dr Lee Soo Chin
Published by HT Digital Content Services with permission from Health Daily Digest....